Trademark: 74437742
Status Date
Friday, April 3, 2020
Registration Number
1955540
Registration Date
Tuesday, February 13, 1996
Filing Date
Monday, September 20, 1993
Published for Opposition
Tuesday, March 8, 1994
Cancellation Date
Friday, April 3, 2020
5 extended release capsules for oral administration containing the drug clonidine intended for the treatment of attention deficit hyperactivity disorders and other disorders characterized by excessive autonomic hyperactivity
Apr 3, 2020
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Jul 4, 2007
Automatic Update Of Assignment Of Ownership
Aug 23, 2006
Case File In Ticrs
Apr 11, 2006
Registered And Renewed (First Renewal - 10 Yrs)
Apr 11, 2006
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jan 27, 2006
Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Mar 31, 2006
Assigned To Paralegal
Jan 27, 2006
Teas Section 8 & 9 Received
Apr 19, 2002
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Feb 11, 2002
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Feb 13, 1996
Registered-Principal Register
Nov 9, 1995
Opposition Terminated No. 999999
Aug 30, 1995
Opposition Dismissed No. 999999
Aug 16, 1994
Opposition Instituted No. 999999
Apr 4, 1994
Extension Of Time To Oppose Received
Mar 8, 1994
Published For Opposition
Feb 4, 1994
Notice Of Publication
Jan 12, 1994
Approved For Pub - Principal Register
Jan 6, 1994
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
